skip to main content

Title: Gemtuzumab ozogamicin (Mylotarg®) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell;Adulto Leukemia Groups

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;  [1]
  1. Leiden
Publication Date:
OSTI Identifier:
1235456
Resource Type:
Journal Article
Resource Relation:
Journal Name: Leukemia; Journal Volume: 19
Research Org:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Org:
DOE - BASIC ENERGY SCIENCES
Country of Publication:
United States
Language:
ENGLISH